Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
114 participants
INTERVENTIONAL
2020-10-15
2026-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Outcomes Using Technology for Children Who Are DHH
NCT02998164
Training Language and Literacy for Children Who Use CIs
NCT03582566
Language Development in Cochlear Implant Children
NCT04595552
A Comparison of Language Intervention Programs
NCT00033150
Baby Navigator Intervention to Improve Outcomes of Toddlers With Communication Delays
NCT05215145
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Technology Assisted Language Intervention (TALI)
Augmentative and alternative communication software incorporated into active speech-language therapy
Technology assisted language intervention
speech language therapy that has integrated technology delivered through specific software on an iPad
Treatment as Usual
Speech language therapy child is typically receiving (no change to current care)
Treatment as usual
No change will occur to the current ongoing speech-language therapy being delivered.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Technology assisted language intervention
speech language therapy that has integrated technology delivered through specific software on an iPad
Treatment as usual
No change will occur to the current ongoing speech-language therapy being delivered.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Documented permanent bilateral hearing loss with severity levels clinically defined moderate to profound).
* Identified with a language deficit, defined by either the ratio of language standard scores to nonverbal intelligence quotient \<.85 or a differences in nonverbal IQ and language standard scores of 10 points. Language scores may either be receptive or expressive.
* Currently receiving speech-language therapy.
Exclusion Criteria
* primary language other than English
* significant motor impairments
* nonverbal IQ \<80
* children with severe communication disorders (i.e. autism spectrum disorders).
3 Years
10 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Children's Hospital Medical Center, Cincinnati
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jareen Meinzen-Derr
Role: PRINCIPAL_INVESTIGATOR
Children's Hospital Medical Center, Cincinnati
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Children's Hospital of Colorado
Aurora, Colorado, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.